Indication · Cardiology
Cardiogenic shock
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
62
Cleared or approved since 2000
PMA and De Novo
12
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
32
131 device trials in all
Devices
62 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Impella RP System
Abiomed, Inc. · PMA · Temporary Non-Roller Type Right Heart Support Blood Pump · newest 2025 · 14 decisions
- Impella 2.5
Abiomed, Inc. · PMA · Temporary Non-Roller Type Left Heart Support Blood Pump · newest 2025 · 10 decisions
- Impella Ventricular Support Systems
Abiomed, Inc. · PMA · Temporary Non-Roller Type Left Heart Support Blood Pump · newest 2023 · 8 decisions
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)Pivotal-lookingRecruiting
Supira MedicalNot on our public-company list
NCT07296744 · 358 participants (planned) · Start May 11, 2026 · Primary completion Nov 2027
Device: The Supira System; Impella · For: Coronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology and 1 more
Sites: Loma Linda, California; Sacramento, California; Thousand Oaks, California · 27 sites in all
University Hospital of CologneAcademic, hospital or other
NCT07655479 · 115 participants (planned) · Start Apr 23, 2026 · Primary completion Oct 2028
Device: Escalation to more capable microaxial flow-pump (Impella 5.5) · For: Cardiogenic Shock Post Myocardial Infarction
Sites: Düsseldorf, Germany; Kiel, Germany; Cologne, Germany
- Pulmonary Artery Catheter in Cardiogenic Shock TrialPivotal-lookingRecruiting
Tufts Medical CenterAcademic, hospital or other
NCT05485376 · 400 participants (planned) · Start Aug 23, 2022 · Primary completion Sep 1, 2027
Device: Pulmonary Artery Catheter · For: Cardiogenic Shock; Heart Failure
Sites: Boston, Massachusetts
128 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- System, Balloon, Intra-Aortic And Control (DSP)35
- Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)7
- Blood Pump For Ecmo, Long-Term (> 6 Hours) Use (QNR)7
- Temporary Non-Roller Type Right Heart Support Blood Pump (PYX)5
- Dual Lumen Ecmo Cannula (PZS)4
- Oxygenator, Long Term Support Greater Than 6 Hours (BYS)2
- Single Lumen Ecmo Cannula (QHW)1
- Tubing, Long Term Support Greater Than 6 Hours (QWF)1
Research
- Device studies on cardiogenic shock across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.